AbbVie Inc. (ABBV) vs Meta Platforms, Inc. (META)

AbbVie Inc. is a pharmaceutical company with significant exposure to immunology through Humira, Skyrizi, and Rinvoq, and to oncology through Imbruvica and Venclexta. The company was spun off from Abbott in early 2013. Its 2020 acquisition of Allergan expanded its portfolio with additional products in aesthetics, including Botox. In 2024, AbbVie further strengthened its business through the acquisitions of Cerevel in neuroscience and ImmunoGen in oncology.

Meta Platforms, Inc. is the world’s largest social media company, reaching nearly 4 billion monthly active users globally. Its core business, known as the Family of Apps, includes Facebook, Instagram, Messenger, and WhatsApp. Users rely on these platforms for a wide range of activities, from staying connected with friends and following public figures to operating digital businesses at no cost. Meta monetizes its ecosystem by using customer data generated across its apps to sell advertising to digital marketers. Although the company has invested significantly in Reality Labs, that segment still represents only a small portion of Meta’s total revenue.